Blueprint Medicines: Q1 Earnings Snapshot
Blueprint Medicines: Q4 Earnings Snapshot
The Chart of the Day belongs to the cancer biomedical company Blueprint Medicines (BPMC) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical...
The precision-treatment company saw stronger-than-expected sales in its first full quarter following the launch of Ayvakit.
Blueprint Medicines: Q3 Earnings Snapshot
/PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective October 1, 2023, the Compensation Committee of Blueprint...
/PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective September 1, 2023, the Compensation Committee of Blueprint...
/PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective August 1, 2023, the Compensation Committee of Blueprint...
The company had generally improved earnings.
Blueprint Medicines: Q2 Earnings Snapshot